USA - NASDAQ:CELH - US15118V2079 - Common Stock
The current stock price of CELH is 63.35 USD. In the past month the price increased by 16.47%. In the past year, price increased by 100.1%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| KO | COCA-COLA CO/THE | 23.47 | 300.01B | ||
| PEP | PEPSICO INC | 19.31 | 207.22B | ||
| MNST | MONSTER BEVERAGE CORP | 39.6 | 68.05B | ||
| CCEP | COCA-COLA EUROPACIFIC PARTNE | 23.69 | 41.52B | ||
| KDP | KEURIG DR PEPPER INC | 13.58 | 36.90B | ||
| FMX | FOMENTO ECONOMICO MEX-SP ADR | 4.36 | 32.98B | ||
| AKO.B | EMBOTELLADORA ANDINA-ADR B | N/A | 22.84B | ||
| AKO.A | EMBOTELLADORA ANDINA-ADR A | N/A | 19.06B | ||
| KOF | COCA-COLA FEMSA SAB-SP ADR | 14.26 | 18.27B | ||
| COKE | COCA-COLA CONSOLIDATED INC | 1.7 | 11.09B | ||
| PRMB | PRIMO BRANDS CORP | 19.76 | 8.34B | ||
| FIZZ | NATIONAL BEVERAGE CORP | 18.02 | 3.36B |
Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. The company is headquartered in Boca Raton, Florida and currently employs 1,073 full-time employees. The company went IPO on 2006-10-10. The firm's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The company also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
CELSIUS HOLDINGS INC
2424 N. Federal Hwy, Suite 208
Boca Raton FLORIDA 33431 US
CEO: John Fieldly
Employees: 1073
Phone: 15612762239
Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. The company is headquartered in Boca Raton, Florida and currently employs 1,073 full-time employees. The company went IPO on 2006-10-10. The firm's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The company also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
The current stock price of CELH is 63.35 USD. The price increased by 2.26% in the last trading session.
CELH does not pay a dividend.
CELH has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
29 analysts have analysed CELH and the average price target is 66.73 USD. This implies a price increase of 5.34% is expected in the next year compared to the current price of 63.35.
The PE ratio for CELSIUS HOLDINGS INC (CELH) is 117.31. This is based on the reported non-GAAP earnings per share of 0.54 and the current share price of 63.35 USD.
CELSIUS HOLDINGS INC (CELH) currently has 1073 employees.
ChartMill assigns a technical rating of 10 / 10 to CELH. When comparing the yearly performance of all stocks, CELH is one of the better performing stocks in the market, outperforming 93.98% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CELH. While CELH has a great health rating, there are worries on its profitability.
Over the last trailing twelve months CELH reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS decreased by -46.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.76% | ||
| ROA | 2.53% | ||
| ROE | 4.59% | ||
| Debt/Equity | 0.41 |
29 analysts have analysed CELH and the average price target is 66.73 USD. This implies a price increase of 5.34% is expected in the next year compared to the current price of 63.35.
For the next year, analysts expect an EPS growth of 154.25% and a revenue growth 80.67% for CELH